Seroprevalence of Human Immunodeficiency Virus Type 1 Among Pregnant Women

John Repke, Timothy R. Townsend, Jacqueline S. Coberly, Geraldine M. McQuillan, Neal A. Halsey, Thomas C. Quinn

Research output: Contribution to journalArticle

3 Scopus citations

Abstract

Five (0.74%) of 678 women delivering in 1985 at a tertiary referral hospital for high-risk pregnancies and 16 (1.34%) of 1198 women visiting an urban prenatal obstetrics clinic in 1986-1987 had serologic evidence of human immunodeficiency virus type 1 (HIV-1) infection. Unlinked testing (removal of personal identifiers from the blood specimen and the epidemiologic data sheet) of residual serum from hepatitis B virus serologic testing was used. Neither age, marital status, payor status, nor serologic markers of hepatitis B virus infection was useful in identifying women at riskfor HIV-1 infection. As a result of these data, we have initiated a program in which counseling is offered to all women and testing for those who consent. Unlinked testing of women who refuse consent is performed for epidemiologic purposes. This will allow us to continue to plan for health care resource needs and to track the course of the epidemic in various subgroups of pregnant women.

Original languageEnglish (US)
Pages (from-to)293-295
Number of pages3
JournalAmerican Journal of Perinatology
Volume9
Issue number4
DOIs
StatePublished - Jan 1 1992

All Science Journal Classification (ASJC) codes

  • Pediatrics, Perinatology, and Child Health
  • Obstetrics and Gynecology

Fingerprint Dive into the research topics of 'Seroprevalence of Human Immunodeficiency Virus Type 1 Among Pregnant Women'. Together they form a unique fingerprint.

  • Cite this

    Repke, J., Townsend, T. R., Coberly, J. S., McQuillan, G. M., Halsey, N. A., & Quinn, T. C. (1992). Seroprevalence of Human Immunodeficiency Virus Type 1 Among Pregnant Women. American Journal of Perinatology, 9(4), 293-295. https://doi.org/10.1055/s-2007-999243